Fast Company names most innovative companies in healthcare

The healthcare industry continues to see a surge in technology and innovations intended to improve patient outcomes and boost efficiencies. Some companies in particular are rising above the fray with their solutions, according to Fast Company, which ranked the most innovative companies for 2019 across industries and overall.

The publication ranks the businesses based on their profound impact on both industry and culture, and noted how the companies are “creating the future today.”

Here are the top 10 honorees in the healthcare sector:

  1. Modern Fertility––simplifies a direct-to-consumer fertility test for $159
  2. Osso VR­­––designs virtual training systems to teach surgical skills
  3. Iora Health––a value-based care company that reimaged primary care for Medicare patients
  4. Oscar Health––a startup health insurance provider that relies heavily on technology
  5. Virta Health­­––addresses type 2 diabetes without medicine or surgery
  6. Adherium––Manages chronic respiratory disease with a smart inhaler
  7. Kaiser Permanente––California health system with new investments in housing in Oakland, Baltimore and Portland
  8. One Medical––enables employers such as Airbnb and Levi’s with concierge care for their employees
  9. Health Recovery Solutions (HRS)––leverages telehealth to help chronically ill patients at home manage their conditions
  10. Stimwave Technologies­­––alleviates pain with microchips

See the list here.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.